Procjena prijelazne stabilnosti dvopodručnog energetskog sustava s CSC-STATCOM-om zasnovanom na LQR-u

A current source converter (CSC) based static synchronous compensator (STATCOM) is a shunt flexible AC transmission system (FACTS) device, which has a vital role as a stability support for small and large transient instability in an interconnected power network. A robust linear quadratic regulator (LQR) based controller for CSC-STATCOM is proposed. In this paper, LQR based CSC-STATCOM is designed to enhance the transient stability of two-area two-machine power system. First of all, modeling & LQR based controller design for CSC-STATCOM are described. After that, the impact of the proposed scheme on the test system with different disturbances is demonstrated. The feasibility of the proposed scheme is demonstrated through simulation in MATLAB and the simulation results show an improvement in the transient stability of power system with CSC-STATCOM. Also, the robustness and effectiveness of CSC-STATCOM are better rather than other shunt FACTS devices (SVC & VSC-STATCOM) in this paper.Statički sinkroni kompenzator (STATCOM) zasnovan na pretvaraču strujnog izvora (CSC) je uređaj za izmjenični prijenos s fleksibilnim "shuntom" (FACTS), koji značajno doprinosi stabilnosti malih i srednjih prijelaznih nestabilnosti u međusobno povezanoj energetskoj mreži. Ovdje je predložen robusni sustav upravljanja zasnovan na linearnom kvadratičnom regulatoru (LQR) za CSC-STATCOM. U ovom radu, CSC-STATCOM zasnovan na LQR-u dizajniran je za povećanje stabilnosti dvopodručnog energetskog sustava s dva motora. Prvo su opisani postupak modeliranja te upravljački sustav zasnovan na LQR-u za CSC-STATCOM. Nakon toga, prikazan je utjecaj predstavljene sheme na ispitni sustav uz prisutnost različitih poremećaja. Provedivost predstavljenog pristupa je prikazana kroz MATLAB simulacije čiji rezultati prikazuju poboljšanje u prijelaznoj stabilnosti energetskog sustava s CSC-STATCOM-om. Također, u ovom radu je prikazana veća robusnost i efikasnost CSC-STATCOM "shunt" FACTS uređaja u odnosu na SVC i VSC-STATCOM

Neuroprotective therapies in the NICU in preterm infants:present and future (Neonatal Neurocritical Care Series)

The survival of preterm infants has steadily improved thanks to advances in perinatal and neonatal intensive clinical care. The focus is now on finding ways to improve morbidities, especially neurological outcomes. Although antenatal steroids and magnesium for preterm infants have become routine therapies, studies have mainly demonstrated short-term benefits for antenatal steroid therapy but limited evidence for impact on long-term neurodevelopmental outcomes. Further advances in neuroprotective and neurorestorative therapies, improved neuromonitoring modalities to optimize recruitment in trials, and improved biomarkers to assess the response to treatment are essential. Among the most promising agents, multipotential stem cells, immunomodulation, and anti-inflammatory therapies can improve neural outcomes in preclinical studies and are the subject of considerable ongoing research. In the meantime, bundles of care protecting and nurturing the brain in the neonatal intensive care unit and beyond should be widely implemented in an effort to limit injury and promote neuroplasticity. IMPACT: With improved survival of preterm infants due to improved antenatal and neonatal care, our focus must now be to improve long-term neurological and neurodevelopmental outcomes. This review details the multifactorial pathogenesis of preterm brain injury and neuroprotective strategies in use at present, including antenatal care, seizure management and non-pharmacological NICU care. We discuss treatment strategies that are being evaluated as potential interventions to improve the neurodevelopmental outcomes of infants born prematurely.</p

Optical imaging of the peri-tumoral inflammatory response in breast cancer

<p>Abstract</p> <p>Purpose</p> <p>Peri-tumoral inflammation is a common tumor response that plays a central role in tumor invasion and metastasis, and inflammatory cell recruitment is essential to this process. The purpose of this study was to determine whether injected fluorescently-labeled monocytes accumulate within murine breast tumors and are visible with optical imaging.</p> <p>Materials and methods</p> <p>Murine monocytes were labeled with the fluorescent dye DiD and subsequently injected intravenously into 6 transgenic MMTV-PymT tumor-bearing mice and 6 FVB/n control mice without tumors. Optical imaging (OI) was performed before and after cell injection. Ratios of post-injection to pre-injection fluorescent signal intensity of the tumors (MMTV-PymT mice) and mammary tissue (FVB/n controls) were calculated and statistically compared.</p> <p>Results</p> <p>MMTV-PymT breast tumors had an average post/pre signal intensity ratio of 1.8+/- 0.2 (range 1.1-2.7). Control mammary tissue had an average post/pre signal intensity ratio of 1.1 +/- 0.1 (range, 0.4 to 1.4). The p-value for the difference between the ratios was less than 0.05. Confocal fluorescence microscopy confirmed the presence of DiD-labeled cells within the breast tumors.</p> <p>Conclusion</p> <p>Murine monocytes accumulate at the site of breast cancer development in this transgenic model, providing evidence that peri-tumoral inflammatory cell recruitment can be evaluated non-invasively using optical imaging.</p

Tetrahydrobiopterin in antenatal brain hypoxia-ischemia-induced motor impairments and cerebral palsy

Antenatal brain hypoxia-ischemia, which occurs in cerebral palsy, is considered a significant cause of motor impairments in children. The mechanisms by which antenatal hypoxia-ischemia causes brain injury and motor deficits still need to be elucidated. Tetrahydrobiopterin is an important enzyme cofactor that is necessary to produce neurotransmitters and to maintain the redox status of the brain. A genetic deficiency of this cofactor from mutations of biosynthetic or recycling enzymes is a well-recognized factor in the development of childhood neurological disorders characterized by motor impairments, developmental delay, and encephalopathy. Experimental hypoxia-ischemia causes a decline in the availability of tetrahydrobiopterin in the immature brain. This decline coincides with the loss of brain function, suggesting this occurrence contributes to neuronal dysfunction and motor impairments. One possible mechanism linking tetrahydrobiopterin deficiency, hypoxia-ischemia, and neuronal injury is oxidative injury. Evidence of the central role of the developmental biology of tetrahydrobiopterin in response to hypoxic ischemic brain injury, especially the development of motor deficits, is discussed

Drug-induced permeabilization of parasite's digestive vacuole is a key trigger of programmed cell death in Plasmodium falciparum

10.1038/cddis.2011.97Cell Death and Disease210